This chemical is primarily used in the field of radiopharmaceuticals and nuclear medicine. It serves as a key intermediate in the synthesis of radiolabeled compounds, particularly for positron emission tomography (PET) imaging. The compound is often employed in the preparation of radiopharmaceuticals that target specific biological processes or disease markers, such as cancer. Its structure allows for efficient incorporation of radioactive isotopes, such as fluorine-18, into complex molecules, enabling the creation of highly specific imaging agents. Additionally, it is utilized in research settings for developing new diagnostic tools and studying molecular interactions in vivo. Its role in advancing medical imaging and diagnostic techniques makes it a valuable component in modern healthcare and biomedical research.